During the past decade, Blue Note Therapeutics conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blue Note Therapeutics" #1 collaborator was "Healthcare Innovation Technology Lab" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Blue Note Therapeutics" are "Breast Cancer Female" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Blue Note Therapeutics" in a lesser frequency.

Most popular intervention types in "Blue Note Therapeutics" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "BNT103" (1 trials), "Long-term follow-up of attune™" (1 trials) and "Long-term follow-up of cerena™" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blue Note Therapeutics" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Blue Note Therapeutics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Blue Note Therapeutics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blue Note Therapeutics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".